Intraocular Pressure

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the AquaLumen, a subconjunctival bypass technology to lower IOP in patients with glaucoma.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the benefits of using AlloFlo to create a cyclodialysis cleft in patients with glaucoma.

Patients with primary open-angle glaucoma or ocular hypertension who received QLS-111 experienced lower IOP in two phase 2 trials, according to a press release from Qlaris Bio.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, explains excimer laser trabeculostomy for the treatment of glaucoma.

KOLOA, Hawaii — Intracranial pressure may be just as critical of a factor in the progression of glaucoma as IOP, according to a speaker here at Hawaiian Eye 2025.

KOLOA, Hawaii — Ophthalmologists must know how to identify and manage pseudoexfoliation glaucoma, one of the most damaging forms of the disease, according to a speaker at Hawaiian Eye 2025.

Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from Glaukos.

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy, to strengthen its clinical-stage pipeline, according to a press release.

Stand-alone canaloplasty and trabeculotomy with the Omni surgical system showed positive real-world outcomes in reducing IOP and medication use, according to a study published in American Journal of Ophthalmology.

Despite a worldwide need for more corneal transplant tissue, few options exist beyond human donors.